2. Immunology/Inflammation
  3. CD3
  4. Pasotuxizumab

Pasotuxizumab  (Synonyms: 帕妥昔珠单抗; BAY 2010112; AMG 212)

目录号: HY-P99802 纯度: 98.02%
COA

摩尔计算器

Pasotuxizumab (BAY 2010112) 是一种 PSMA 和 CD3 双特异性的 T 细胞接合剂 (BiTE)。Pasotuxizumab 可结合 CD3 和 PSMA，对人 CD3 和 PSMA 的 KD 分别为 9.4 nM 和 47.0 nM。Pasotuxizumab 可用于转移性去势抵抗性前列腺癌 (mCRPC) 的研究。

MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务

我们将采用定制合成服务的方式为您快速提供所需产品和技术服务

CAS No. : 1442657-12-6

1.  客户无需承担相应的运输费用。

2.  同一机构（单位）同一产品试用装仅限申领一次，同一机构（单位）一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户。

规格 价格 是否有货 数量
1 mg ￥4500
In-stock
5 mg   询价  
10 mg   询价  

* Please select Quantity before adding items.

Customer Review

Pasotuxizumab 相关抗体

Top Publications Citing Use of Products

  • 生物活性

  • 纯度 & 产品资料

  • 参考文献

生物活性

Pasotuxizumab (BAY 2010112) is a PSMA and CD3 bispecific T-cell engager (BiTE). Pasotuxizumab binds to CD3 and PSMA with KDs of 9.4 nM and 47.0 nM for human CD3 and PSMA. Pasotuxizumab can be used for research of metastatic castration-resistant prostate cancer (mCRPC)[1][2].

同型

(scFv-heavy-kappa)-(scFv-heavy-lambda)
种属

Chimeric; Humanized
IC50 & Target

KDs: 9.4 nM and 16.3 nM for human and cynomolgus monkey CD3.
KDs: 47.0 nM and 212.6 nM for human and cynomolgus monkey PSMA.
体外研究
(In Vitro)

Pasotuxizumab (约 0-100 ng/mL，48 小时) 可激活 CD4+ 和 CD8+ T 细胞群，EC50 为 3.4-6.7 ng/mL (人) 和 13.7-21.2 ng/mL (食蟹猴)[2]。
Pasotuxizumab (约 0-100 ng/mL，48 小时) 增加 T 细胞中干扰素-γ、TNF-α、IL-2 和 IL-10 的释放[2]。

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Pasotuxizumab 相关抗体:
体内研究
(In Vivo)

Rafivirumab (0.005-5 mg/kg，尾静脉注射，每日一次) 抑制 PC-3-huPSMA 小鼠异种移植模型中的肿瘤生长[2]。
Rafivirumab (0.1-1 mg/kg，静脉推注给药) 在 BALB/c 小鼠中表现出较低的血清清除率[2]。

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: PC-3-huPSMA mouse xenograft model[2]
Dosage: 0.005-5 mg/kg
Administration: i.v., once daily
Result: Inhibited tumor growth by 86% (0.005 mg/kg/d) and 99% (5 mg/kg/d).
Animal Model: BALB/c mice (PK Assay)[2]
Dosage: 0.1, 0.3, and 1 mg/kg
Administration: i.v. bolus administration or s.c.
Result: Pharmacokinetic profile of Rafivirumab.
Dose (mg/kg) AUC (mg h/L) CLmatrix (L/h/kg) T1/2 (h) F (%)
i.v. (0.3) 0.93 0.32 9.7 100
s.c. (0.3) 0.17 11 18
Clinical Trial
CAS 号
性状

液体

颜色

Colorless to light yellow

中文名称

帕妥昔珠单抗
运输条件

Shipping with dry ice.
储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.
Format
  • (scFv-heavy-kappa)-(scFv-heavy-lambda)
纯度 & 产品资料
参考文献

Pasotuxizumab 相关分类

  • 摩尔计算器

  • 稀释计算器

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量   浓度   体积   分子量 *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start) × 体积 (start) = 浓度 (final) × 体积 (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Keywords:

Pasotuxizumab1442657-12-6BAY 2010112 AMG 212帕妥昔珠单抗BAY2010112BAY-2010112AMG212AMG 212AMG-212CD3Cluster of differentiation 3mCRPCcancerT-cellBiTEPC-3prostate cancerInhibitorinhibitorinhibit

您最近查看的产品:

Your information is safe with us. * Required Fields.

   产品名称：

  

* 需求量：

* 客户姓名：

 

* Email：

* 电话：

 

* 公司或机构名称：

   留言给我们：

Bulk Inquiry

Inquiry Information

产品名称：
Pasotuxizumab
目录号：
HY-P99802
需求量：

Request for HNMR Report

Please fill out this form to request the QC report. We will send it to your Email address shortly.

Your information is safe with us. * Required Fields.

   产品名称：

  

* Lot #：

* 客户姓名：

 

* Email：

   电话：

 

* 部门：

* 公司或机构名称：

 

   留言给我们：

Request for HNMR Report

We have received your request and will respond to you as soon as possible.

嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z